Technology Transfers To Least-Developed Countries Often Not An Option - IFPMA Report
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The transfer of technology developed by high-end research-based pharmaceutical companies to operations in developing countries is increasingly common, but rarely simple